200mg Gemcitabine Injection IP

Name: 200mg Gemcitabine Injection IP
Brand: Vikshar Healthcare Private Limited
Price: 13.80 INR
Availability: InStock

Price 13.80 INR/ Piece

Get a Price/Quote

MOQ : 10 Pieces

200mg Gemcitabine Injection IP Specification

Indication
Breast, lung, ovarian, pancreatic cancer

Salt Composition
Gemcitabine IP 200 mg

Dosage Form
Injection

Packaging Type
Box with vial

Origin of Medicine
India

Pacakaging (Quantity Per Box)
1 vial per box

Life Span
Check expiry on pack

Drug Type
Allopathic

Ingredients
Gemcitabine Hydrochloride

Physical Form
Liquid

Function
Anticancer (Cytotoxic Agent)

Recommended For
Cancer treatment

Dosage
200 mg per vial

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 30C

Sterile Preparation
Yes

Prescription status
Prescription only

Grade
Medicine Grade

Language
English/Hindi

Box Color
White & Blue

Strength
200 mg

Administration Route
Intravenous

Single Dose Vial
Yes

200mg Gemcitabine Injection IP Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About 200mg Gemcitabine Injection IP

Discover the transcendent efficacy of Citafine-200, a renowned Gemcitabine Injection IP (200 mg) tailored for adult patients battling cancer. Backed by an unprecedented price cut for advance purchase, Citafine-200 stands out as an antineoplastic agent addressing breast, lung, ovarian, and pancreatic cancers. The product is supplied in a single dose sterile vial, featuring a medicine-grade liquid form within a white and blue box. Exclusively for intravenous administration under prescription, it is meticulously prepared to ensure optimal safety and potency. Trust Citafine-200's exceptional quality for your cancer treatment needs.

Key Features and Competitive Advantages of Citafine-200

Citafine-200 Gemcitabine Injection IP (200 mg) boasts a medicine-grade, sterile preparation designed for intravenous use. Manufactured using advanced processes in India, its cytotoxic action is specialized for various cancer types, including breast, lung, ovarian, and pancreatic. The liquid form allows precise dosing and swift administration. Citafine-200 offers a unique combination of renowned efficacy and competitive price cuts for advance purchases, making it a preferred choice for hospitals, clinics, and healthcare providers.

Secure Packaging and Main Market Details

Citafine-200 is packaged securely in a single vial per white and blue box, ensuring safe transport and preservation under 30C. Our export and supply operations prioritize secure shipping, with drop-off and charge details arranged for seamless delivery. The main domestic market covers India, with FOB port services available for major export destinations. Customers can rely on our dedicated support for timely, hassle-free distribution within the specified shelf life and storage requirements.

FAQ's of 200mg Gemcitabine Injection IP:

Q: How is 200mg Gemcitabine Injection IP administered?

A: This medication is administered intravenously, strictly under the supervision and direction of a physician, ensuring the correct dosage and minimizing potential side effects.

Q: What cancers is Citafine-200 recommended for?

A: Citafine-200 is indicated for the treatment of breast, lung, ovarian, and pancreatic cancers, as identified by your oncology specialist.

Q: When should I use 200 mg Gemcitabine Injection IP?

A: Usage and scheduling depend on your treatment plan, as directed by your physician. Never self-administer; always follow the healthcare professional's instructions.